- decreased total body fat amount / IMPC
- polycystic kidney / IMPC
- decreased prepulse inhibition / IMPC
- fibro-osseous lesion / IMPC
- abnormal vertebrae morphology / IMPC
- increased circulating alanine transaminase level / IMPC
- abnormal optic disk morphology / IMPC
- hyperplasia / IMPC
- increased bone mineral density / IMPC
- increased bone mineral content / IMPC
- short tibia / IMPC
- increased circulating aspartate transaminase level / IMPC
B6;129S5-Plekhm1Gt(OST201689)Lex/Orl
Status | Available to order |
EMMA ID | EM:02334 |
International strain name | B6;129S5-Plekhm1Gt(OST201689)Lex/Orl |
Alternative name | LEXKO-0354 |
Strain type | Gene-trap |
Allele/Transgene symbol | Plekhm1Gt(OST201689)Lex |
Gene/Transgene symbol | Plekhm1 |
Information from provider
Provider | Lexicon Genetics, Inc. |
Provider affiliation | Lexicon Pharmaceuticals |
Phenotypic information | No Notable Phenotype. |
References | None available |
Information from EMMA
Archiving centre | Institut de Transgenose, INTRAGENE, Orléans, France |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Intermediate osteopetrosis / Orphanet_210110
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- abnormal osteoclast physiology / MGI
- no abnormal phenotype detected / MGI
- decreased lysosomal enzyme secretion / MGI
- abnormal osteoclast morphology / MGI
- decreased osteoblast cell number / MGI
- decreased bone resorption / MGI
- abnormal lysosome morphology / MGI
- increased bone trabecula number / MGI
- increased trabecular bone mass / MGI
- increased trabecular bone volume / MGI
- decreased bone trabecular spacing / MGI
- decreased bone ossification / MGI
- decreased bone mineralization / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).